An Extension Study to Evaluate the Long Term Safety, Tolerability and Efficacy of Aliskiren Compared to Enalapril in Pediatric Hypertensive Patients 6-17 Years of Age
This study is currently recruiting participants.
Verified January 2013 by Novartis
Study NCT01151410
Information provided by Novartis
First Received on June 23, 2010.
Last Updated on January 2, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
